Human Microbiome: The Interface of Immunology and Microbiology (MOC)
You can earn up to 1.5 AMA PRA Category 1 Credit(s)™. This activity has also been designated by the ABAI for 1.5 MOC Part II Self-Assessment credits. Cost:
$30 $15 for College Members, $45 $25 for non-members.
These presentations will review: 1) the role of microbiome in the pathogenesis of asthma, related traits and other inflammatory disease; 2) how gut microbiota dysbiosis contributes to aberrant immune development and the development of allergic disease and asthma; and 3) how asthma is a heterogeneous disease with differeing clinical and inflammatory phenotypes, especially among adults; to include discussion of recent observations of airway dysbiosis in asthma and relationships to phenotypic features of the disease, including possible treatment implications.
Release Date: 12/15/2015
Expiration Date: 12/14/2018
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• Discuss facets of modulation of gut microbiota that lead to disruption of host-microorganism homeostasis and contributes to the development of non-communicable inflammatory diseases
• Explain how gut microbiota dysbiosis contributes to aberrant immune development and the development of allergic disease and asthma
• Discuss the implications of gut microbiota modification for treatment and prevention of allergic disease and asthma
Michael B. Foggs, MD, FACAAI
Todd A. Mahr, MD, FACAAI
Fernando D. Martinez, MD
Lanny J. Rosenwasser, MD, FACAAI
Yvonne Huang, MD
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance
- 1.50 MOC